September 24, 2026

A New Era for Pancreatic Cancer: How Baptist Health Research Helped Get Us Here

Pancreatic adenocarcinoma, the most common form of pancreatic cancer, accounts for roughly 90 to 95 percent of cases. It's notoriously difficult to catch early, because symptoms often don't appear until the disease has already spread

Baptist Health South Florida

September 23, 2026

Matthew David Hall, M.D., MBA, Installed as Endowed Chair in Pediatric Oncology at Baptist Health Herbert Wertheim Cancer Institute

Matthew D. Hall, M.D., MBA, lead pediatric radiation oncologist at Baptist Health Herbert Wertheim Cancer Institute, part of Baptist Health Cancer Care, was formally installed as the Endowed Chair in Pediatric Radiation Oncology.

Baptist Health South Florida

September 23, 2026

Aurelio B. Castrellon, M.D., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist

Board-certified medical oncologist Aurelio B. Castrellon, M.D., has joined the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health in Boynton Beach.

Baptist Health South Florida

September 23, 2026

Kfir Ben-David, M.D., FACS, Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Surgical Oncologist

Fellowship-trained surgical oncologist Kfir Ben-David, M.D., FACS, has joined the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital.

Baptist Health South Florida

September 15, 2026

Dana-Farber Research News 09.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 16 - 31.

Dana-Farber

September 15, 2026

Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027

U.S. News & World Report has recognized Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as the #1 pediatric cancer program in the nation in its 2026-2027 Best Children’s Hospitals report.

Dana-Farber

September 03, 2026

Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist

 Board-certified medical oncologist and hematologist Spencer Streit, D.O., has joined the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital.

Baptist Health South Florida

September 03, 2026

Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist

Baptist Health Wertheim Cancer Institute is pleased to welcome Kriti Ahuja, M.D., a board-certified medical oncologist specializing in breast cancer

Baptist Health South Florida

September 02, 2026

Targeting CDK2 Could Boost Immunotherapy Response in Patients With a Wide Range of Cancers, According to Dana-Farber Science

New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which are currently being tested as treatments that slow the growth of a narrow range of cancers, could potentially be more broadly applicable to a wide range of cancers when combined with immunotherapy.

Dana-Farber

September 01, 2026

Dana-Farber Research News 09.01.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 1 - 15.

Dana-Farber